Marcus Corp executive reports initial share holdings
Marcus Corp executive Jeffry Frank Tomachek, President of Marcus Theatres, filed an initial ownership report showing his existing equity position in the company.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
Marcus Corp executive Jeffry Frank Tomachek, President of Marcus Theatres, filed an initial ownership report showing his existing equity position in the company. He directly holds multiple blocks of common stock, including 5,454 shares, 1,464 shares, 1,005 shares, 714 shares and smaller amounts from various restricted stock grants.
He also holds several stock option awards on common stock, such as 4,000 options at an exercise price of $15.99 per share expiring in 2033, 3,500 options at $17.04 expiring in 2032, and additional option grants with exercise prices ranging from $12.71 to $41.90 expiring between 2027 and 2031. Footnotes explain that various restricted stock awards vest on long-term schedules tied to service, death, disability or retirement.
Insider Trade Summary
19 transactions reported
Mixed
19 txns
Insider
Tomachek Jeffry Frank
Role
Pres., Marcus Theatres
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 27,450 contracts (Direct);
Common Stock — 9,456.39 shares (Direct)
Footnotes (8)
- F1. Restricted Stock granted December 3, 2004 vest upon death, disability or retirement. Does not include 468 shares previously vested.
- F2. Restricted Stock granted August 31, 2005 vest upon death, disability or retirement. Does not include 468 shares previously vested.
- F3. Restricted stock granted February 22, 2024 vests as follows: 100% after 4th anniversary of date of grant. Does not include 713 shares that vested on February 22, 2026.
- F4. Restricted stock granted February 12, 2025 vests as follows: 50% after 2nd anniversary of date of grant and 100% after 4th anniversary of date of grant.
- F5. Restricted stock granted February 11, 2026 vests as follows: 50% after 2nd anniversary of date of grant and 100% after 4th anniversary of date of grant.
- F6. Restricted stock granted March 1, 2026 vests as follows: 50% after 2nd anniversary of date of grant and 100% after 4th anniversary of date of grant.
- F7. The options originally granted vest as follows: 40% after 2nd anniversary of the date of grant; 60% after 3rd anniversary; 80% after 4th anniversary; and 100% after 5 years.
- F8. The options originally granted vest as follows: 50% after 2nd anniversary of the date of grant; 75% after 3rd anniversary; and 100% after 4 years.
Key Figures
Common stock block: 5,454 shares
Additional common stock block: 1,464 shares
Stock options at $15.99: 4,000 options
+5 more
8 metrics
Common stock block
5,454 shares
Directly held common stock position reported on Form 3
Additional common stock block
1,464 shares
Directly held common stock position reported on Form 3
Stock options at $15.99
4,000 options
Exercise price $15.99; expiration date 2033-03-07
Stock options at $17.04
3,500 options
Exercise price $17.04; expiration date 2032-03-08
Stock options at $21.84
3,588 options
Exercise price $21.84; expiration date 2031-03-09
Stock options at $12.71
1,750 options
Two grants of 875 each; expiration date 2030-05-08
Stock options at $41.90
3,500 options
Exercise price $41.90; expiration date 2029-02-26
Stock options at $31.20
3,500 options
Exercise price $31.20; expiration date 2027-02-28
Key Terms
Restricted stock, Stock Option (Right to Buy), exercise price, expiration date, +1 more
5 terms
Restricted stock financial
"Restricted stock granted February 22, 2024 vests as follows: 100% after 4th anniversary of date of grant."
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy) with underlying security title Common Stock."
exercise price financial
"conversion_or_exercise_price: 15.9900 for stock option expiring 2033-03-07."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2033-03-07T00:00:00.000Z for stock option grant."
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
initial ownership report regulatory
"Form 3 shows Jeffry Frank Tomachek’s existing ownership in Marcus Corp common stock and stock options."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Jeffry Frank Tomachek Form 3 filing for MARCUS CORP (MCS) show?
The Form 3 shows Jeffry Frank Tomachek’s existing ownership in Marcus Corp common stock and stock options. It lists multiple blocks of directly held shares and several option grants with specified exercise prices and expiration dates, but no new purchases or sales.
What stock options are reported for Jeffry Tomachek in the Marcus Corp (MCS) Form 3?
Tomachek reports multiple stock option awards on Marcus Corp common stock. Examples include 4,000 options at an exercise price of $15.99 expiring in 2033 and 3,500 options at $17.04 expiring in 2032, along with other grants priced between $12.71 and $41.90.
What do the restricted stock footnotes in the Marcus Corp Form 3 mean?
The footnotes explain vesting conditions for restricted stock granted on dates such as December 3, 2004 and February 22, 2024. Some vest upon death, disability or retirement, while others vest 50% after two years and 100% after four years from the grant date.
Does Jeffry Tomachek’s Form 3 for Marcus Corp show any insider buying or selling?
The Form 3 is an initial ownership report and shows holdings only, not trades. All entries are recorded as existing positions with unknown transaction codes, and the transaction summary shows zero buys, zero sells and no option exercises in this filing.
When do Jeffry Tomachek’s Marcus Corp stock options reported on Form 3 expire?
The reported stock options have staggered expiration dates from 2027 through 2033. For example, certain grants priced at $31.20 expire in 2027, $27.00 in 2028, $41.90 in 2029, $28.88 and $12.71 in 2030, and $21.84 and $15.99 later through 2033.
AI-generated analysis. How Rhea-AI works. Not financial advice.
